Vancouver Prostate Centre researcher Dr. Artem Cherkasov recently won two competitions in the international CACHE Challenges, leveraging advanced computational methods and artificial intelligence (AI) to find new potential treatment avenues for Parkinson’s disease and COVID-19. Cherkasov’s submissions topped results from dozens of other researchers from leading academic, industry and non-profit sector institutions around the world.
A new avenue to differentiate between prostate cancers is being investigated by Vancouver Coastal Health Research Institute researchers Dr. Alexander Wyatt and Dr. Cameron Herberts.
We know that a nutritious diet plays a key role in good health, but eating well is about more than just meeting physical needs. Healthy eating is a deeply personal journey that supports emotional well-being, strengthens social connections and empowers thriving communities.
A Phase 3, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous Teprotumumab in Participants with Moderate-to-Severe Active Thyroid Eye Disease
Around 30 to 50 per cent of Canadians living with type 1 diabetes (T1D) experience diabetes distress, a psychological state characterized by ongoing frustrations, worries and fears related to managing this complex condition. A pilot study headed by Vancouver Coastal Health Research Institute researcher Dr.
A lesser-known form of dementia that primarily affects the language and speech centres of the brain was the focus of a research study led by Vancouver Coastal Health Research Institute researcher Dr. Ging-Yuek Robin Hsiung and Dr. Katharine Davies. The study gathered perspectives from speech-language pathologists on the communication needs of people with primary progressive aphasia (PPA) and their family members, pinpointing areas for improvement in the care delivery of this patient population.
We are pleased to announce that Dr. M-J Milloy has been appointed interim Director of Research at the British Columbia Centre on Substance Use (BCCSU), effective to June 30, 2026.